Workflow
中化化肥(00297) - 2024 - 年度财报
00297SINOFERT(00297)2025-04-25 14:15

Financial Performance - The company's revenue for 2024 was RMB 21,264,854, a decrease of 2.14% from RMB 21,728,120 in 2023[16] - Gross profit increased to RMB 2,543,838, up 12.54% from RMB 2,259,547 in the previous year[16] - Profit attributable to shareholders rose to RMB 1,061,480, representing a significant increase of 69.91% compared to RMB 625,549 in 2023[16] - Basic earnings per share improved to RMB 0.1511, up from RMB 0.0891 in the prior year[16] - Return on equity increased to 10.55%, compared to 6.52% in 2023, indicating enhanced profitability[16] - The company achieved a revenue of RMB 21.265 billion for the year ending December 31, 2024, with a net profit attributable to shareholders of RMB 1.061 billion, representing a year-on-year growth of 69.49%[58] - Excluding impairment losses related to Yangmei Plain Chemical Co., the adjusted net profit attributable to shareholders for the year was RMB 1.229 billion, a growth of 6.96% compared to RMB 1.149 billion for the previous year[59] - The segment profit for the fiscal year ending December 31, 2024, was RMB 1.38 billion, down from RMB 1.42 billion in the previous year, a decrease of about 3.06%[90][93] - The basic business segment reported a profit of RMB 645 million, a decrease of 4.9% compared to the previous year[90] - The growth business segment achieved a profit of RMB 347 million, a significant increase of 45.11% year-over-year, driven by a 10% increase in compound fertilizer sales and a 59% increase in high-end differentiated compound fertilizer sales[90] - The production business segment's profit was RMB 387 million, a decrease of 23% year-over-year, impacted by a significant drop in synthetic ammonia prices[90] - The net profit margin for the fiscal year ending December 31, 2024, was 4.99%, an increase of 2.11 percentage points compared to the previous year[94] Sales and Market Performance - In 2024, the company achieved a sales volume of 7.21 million tons and a revenue of RMB 21.265 billion, with a net profit of RMB 1.075 billion, representing a year-on-year growth of 57%[20] - The company's shareholder profit reached RMB 1.061 billion, marking a year-on-year increase of 69.49%[20] - The company launched 6 new or upgraded products, including "Huanfeng" and "Weidefeng," achieving a total research output of 1.285 million tons, with sales of Class A products like Lanlin and Kede Feng increasing by 55% year-on-year[60] - The company achieved a 12% year-on-year increase in phosphate fertilizer sales, with differentiated biological phosphate fertilizer sales reaching 250,000 tons, a 14% increase year-on-year[63] - The differentiated compound fertilizer sales for 2024 are projected to be 1.5 million tons, an increase of 160,000 tons year-on-year, with high-end biological products seeing a 59% year-on-year sales growth[64] - The total sales of specialty fertilizers exceeded 110,000 tons in 2024, a year-on-year increase of 20%, with soil health products achieving sales of 30,000 tons, up 11% year-on-year[65] - The company reported a revenue of RMB 410 million from collaborative plant protection in 2024, a 5% increase year-on-year, with a three-year compound growth rate of 17%[66] Research and Development - The company is committed to continuous research and development in crop nutrition products and related technologies[12] - The company launched the "Bio+" technology brand and achieved a research output conversion of 1.285 million tons, with Class A product sales increasing by 55% year-on-year[22] - The company’s research and development efforts are focused on the "Biological +" strategy, with 27 patents granted in key biotechnology areas, enhancing its technological foundation[60] - The company’s innovative "Root-Phosphorus Efficient Coupling Technology" was recognized as a major new agricultural technology in China for 2024, marking a significant achievement in its R&D efforts[47] - The company aims to enhance its integrated R&D capabilities in "nutrient efficiency, biological agents, and soil health" under its "Biological +" strategy[78] Strategic Initiatives - The company aims to lead in bio-fertilizer and soil health innovation, focusing on sustainable agricultural practices[11] - The company has established a comprehensive sales service network covering 95% of arable land in China[12] - Strategic partnerships with international suppliers have been formed to enhance product offerings and market reach[12] - The company signed a strategic cooperation memorandum with the American company for sustainable agricultural development and technology innovation[35] - The company aims to enhance operational management and provide green and efficient crop nutrition products while ensuring stable cash flow for investment decisions[23] - The company plans to celebrate its 20th anniversary in 2025 with a focus on the "Bio+" strategy and sustainable development[23] Environmental and Social Responsibility - The company maintained a 100% utilization rate of phosphogypsum for two consecutive years and received multiple awards for its environmental projects[22] - The company is committed to ensuring food security and supporting farmers' income growth as part of its social responsibility initiatives[78] - The company received the "Leading Environmental Project" award for its "Sinochem Changshan Low Carbon Environmental Comprehensive Management Project" at the 2024 ESG Leading Enterprises event[47] Governance and Management - The company has a strong governance structure with independent non-executive directors overseeing various committees, ensuring compliance and strategic direction[145][146][147] - The company emphasizes its commitment to corporate governance and strategic planning through the establishment of various committees[145][146] - The board of directors consists of seven members, including three executive directors, one non-executive director, and three independent non-executive directors[158] - The company has adopted the corporate governance code as per the listing rules, ensuring compliance and transparency in its operations[155] - The company has experienced a change in board composition, with Mr. Liu Hongsheng resigning as non-executive director and chairman, and Mr. Su Fu appointed as his successor[159] - The company has implemented a mechanism to ensure that the opinions and suggestions of independent non-executive directors are communicated to management for follow-up[164] Employee Development - The group employs approximately 4,371 full-time employees, with compensation structured to align employee interests with company performance and shareholder value[135] - A total of 21,565 training sessions were conducted, amounting to approximately 158,092 hours of training, covering various topics to enhance management skills and overall employee quality[190] - The group emphasizes employee development, with significant training initiatives aimed at improving core competitiveness[190] Financial Management and Risks - The company faces significant financial risks, including market risk, credit risk, and liquidity risk[127] - Market risk encompasses currency risk, interest rate risk, and other price risks, with management employing forward foreign exchange contracts to mitigate potential adverse impacts on financial performance[128] - The group has implemented robust management procedures for credit limits, payment terms, and overdue collections to prevent and control credit risk[130] - Liquidity risk management includes strengthening daily cash position management and maintaining sufficient cash and cash equivalents to meet operational and debt obligations[131]